VIVS
VivoSim Labs, Inc.NASDAQHealthcare$1.69+4.32%ClosedMarket Cap: $4.4M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.56
P/S
31.41
EV/EBITDA
-0.76
DCF Value
$6.01
FCF Yield
-238.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
100.0%
Operating Margin
-8066.2%
Net Margin
-864.1%
ROE
-15.6%
ROA
-17.6%
ROIC
-228.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2026 | $26.0K | 100.0% | $-2.8M | $-2.7M | $-1.84 | — |
| Q2 2026 | $28.0K | 100.0% | $-2.6M | $-2.5M | $-1.74 | — |
| Q1 2026 | $37.0K | 100.0% | $-2.9M | $-2.8M | $-1.94 | — |
| Q4 2025 | $51.0K | 100.0% | $-3.2M | $6.9M | $4.68 | — |
| FY 2025 | $144.0K | 96.5% | $-12.6M | $-2.5M | $-1.70 | — |
| Q3 2025 | $24.0K | 91.7% | $-3.5M | $-3.4M | $-2.29 | — |
| Q2 2025 | $30.0K | 96.7% | $-2.6M | $-2.5M | $-1.70 | — |
| Q1 2025 | $39.0K | 94.9% | $-3.4M | $-3.3M | $-2.74 | — |
| Q4 2024 | $29.0K | 100.0% | $-3.1M | $-3.0M | $-3.07 | — |
| FY 2024 | $109.0K | 100.0% | $-15.1M | $-14.7M | $-19.25 | — |
| Q3 2024 | $5.0K | 100.0% | $-3.7M | $-3.6M | $-4.74 | — |
| Q2 2024 | $0.00 | NaN% | $-4.1M | $-4.0M | $-5.50 | — |